Clinical Trial: Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06842563) titled 'Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial' on Feb. 13.

Brief Summary: The purpose of this clinical trial was to systematically study the clinical performance and accuracy of the human DAB2IP, CHFR and GRASP gene methylation combined test kit (PCR-fluorescent probe method) produced by Jiangsu Kunyuan Biotechnology Co., LTD. The test reagent was compared with the clinical reference standard (pathological diagnosis and/or imaging diagnosis) to verify the clinical performance of the product. At the same time, for each gene that can be detected by the a...